SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001615774-19-002509
Filing Date
2019-02-14
Accepted
2019-02-14 15:35:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A s116132_sc13da.htm SC 13D/A 30137
  Complete submission text file 0001615774-19-002509.txt   31591
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Subject) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89137 | Film No.: 19605465
SIC: 2834 Pharmaceutical Preparations

Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 (650) 688-0822
VIVO VENTURES VII, LLC (Filed by) CIK: 0001565020 (see all company filings)

IRS No.: 274484686 | State of Incorp.: CA
Type: SC 13D/A